Societies, Congresses, and Industry Events
Botulinum toxin research and clinical use span several professional fields, from neurotoxin science and neurology to rehabilitation medicine, dermatology, plastic surgery, and aesthetic medicine. The meetings connected to these fields differ in scientific scope, clinical focus, and commercial participation.
INA and TOXINS are the closest to dedicated neurotoxin science. AAN and AAPM&R place botulinum toxin within therapeutic specialist practice, while IMCAS, AMWC, Vegas Cosmetic Surgery, The Aesthetic Show, and AMWC Korea connect clinical education with the wider medical-aesthetics industry. Their schedules provide a chronological view of where research exchange, professional education, and product visibility occur.
2026 Major Event Calendar
Section titled “2026 Major Event Calendar”The main 2026 meetings connected to the organizations and congress brands covered here span neurotoxin science, therapeutic specialties, and medical aesthetics. Dates refer to the principal congress or annual meeting rather than optional pre-congress courses, registration deadlines, or on-demand access periods.
| Date | Event | Location and format | Status |
|---|---|---|---|
| January 14–17 | TOXINS 2026 🔗 | Madrid, Spain | Concluded |
| January 29–31 | IMCAS World Congress 2026 🔗 | Paris, France, and online | Concluded |
| March 26–28 | AMWC 2026 🔗 | Monte Carlo, Monaco | Concluded |
| April 18–22 | AAN Annual Meeting 🔗 | Chicago, United States, and online | Concluded |
| May 28–30 | Vegas Cosmetic Surgery & Aesthetic Dermatology 🔗 | Las Vegas, United States | Concluded |
| June 19–20 | AMWC Korea 🔗 | Seoul, South Korea | Concluded |
| June 25–28 | The Aesthetic Show 🔗 | Las Vegas, United States | Concluded |
| November 11–14 | AAPM&R Annual Assembly | Orlando, United States, and virtual | Scheduled |
Schedule status checked July 29, 2026. Event dates and formats can change; the linked organizer pages remain the controlling source for registration and travel decisions.
Next Announced Editions
Section titled “Next Announced Editions”Several organizers have already published dates for their next annual meeting. Other series remain listed by their most recently confirmed edition until a new date is announced.
| Date | Event | Location and format |
|---|---|---|
| April 1–3, 2027 | AMWC 2027 | Cannes, France |
| May 1–5, 2027 | AAN Annual Meeting 2027 | Washington, DC, United States, and online |
| June 4–5, 2027 | AMWC Korea 2027 | Seoul, South Korea |
Core Neurotoxin Organizations
Section titled “Core Neurotoxin Organizations”International Neurotoxin Association
Section titled “International Neurotoxin Association”The International Neurotoxin Association (INA) is the most directly relevant scientific society for this field. It describes itself as a not-for-profit international scientific society dedicated to research, education, and understanding of botulinum and other neurotoxins.
INA keeps botulinum toxin inside a broader neurotoxin-science frame rather than treating it only as a cosmetic injectable or a product category. Its membership and programming connect basic science, clinical use, and cross-specialty interpretation.
Website: International Neurotoxin Association 🔗
TOXINS Conference
Section titled “TOXINS Conference”TOXINS is INA’s international conference series focused on basic science and clinical aspects of botulinum and other neurotoxins. The 2026 conference page described the meeting as a venue for developments in neurotoxin science and clinical applications, with relevance to neurology, physical medicine and rehabilitation, dermatology, aesthetic medicine, ophthalmology, otolaryngology, urology, gastroenterology, and pain management.
TOXINS is the most focused event anchor for botulinum toxin as a scientific and clinical category. It is more specific than broad dermatology or aesthetics congresses and sits near the center of the field’s event landscape.
Website: TOXINS 2026 🔗
Therapeutic Clinical Fields
Section titled “Therapeutic Clinical Fields”American Academy of Neurology
Section titled “American Academy of Neurology”The American Academy of Neurology (AAN) is not a botulinum toxin-specific society, but neurology is one of the major therapeutic contexts in which botulinum toxin products are discussed. Movement disorders, dystonia, spasticity-adjacent care, chronic migraine, and other neurologic treatment contexts make AAN meetings and educational materials relevant to the medical side of the toxin field.
The AAN Annual Meeting 2027 is scheduled for May 1–5 in Washington, DC, and online. The Annual Meeting is a broad neurology meeting rather than a product meeting, connecting regulated products and neurologic indications with clinical evidence and specialist practice.
Website: American Academy of Neurology Annual Meeting 🔗
American Academy of Physical Medicine and Rehabilitation
Section titled “American Academy of Physical Medicine and Rehabilitation”The American Academy of Physical Medicine and Rehabilitation (AAPM&R) represents physiatrists and rehabilitation physicians. Its relevance to botulinum toxin comes through spasticity, dystonia, ultrasound-guided procedures, and interventional rehabilitation practice.
AAPM&R’s education structure includes annual meeting activity and spasticity-focused certificate programming. In this context, botulinum toxin is part of a broader functional-management and rehabilitation conversation rather than an aesthetic product comparison.
Website: AAPM&R Annual Assembly 🔗
Aesthetic Medicine Congresses And Exhibitions
Section titled “Aesthetic Medicine Congresses And Exhibitions”IMCAS World Congress
Section titled “IMCAS World Congress”IMCAS World Congress is a large international congress for dermatology, plastic surgery, and aging science. Its program and exhibition environment make it a major visibility point for injectables, devices, procedural education, and aesthetic medicine companies.
IMCAS matters less as a toxin-specific authority and more as a global marketplace of aesthetic practice. It brings toxin brands, injector education, clinical technique discussion, and medical-aesthetics business development into the same setting.
Website: IMCAS World Congress 🔗
AMWC, the Aesthetic & Anti-Aging Medicine World Congress, is one of the major global medical-aesthetics congress brands. Its official materials position the event around aesthetic medicine, surgery, longevity, regenerative medicine, wellness, scientific programming, abstract submission, sponsorship, and exhibition.
Botulinum toxin appears in this environment as part of the wider non-surgical aesthetics market. AMWC helps track the professional and commercial context around injectables, but claims made in congress marketing should not be treated as product evidence without separate clinical or regulatory sources.
Website: AMWC 🔗
Vegas Cosmetic Surgery & Aesthetic Dermatology
Section titled “Vegas Cosmetic Surgery & Aesthetic Dermatology”Vegas Cosmetic Surgery & Aesthetic Dermatology is a multispecialty aesthetic conference in the United States. Its official materials emphasize aesthetic surgery, dermatology, live anatomy-based education, nonsurgical technique, patient safety, and injector-focused programming.
Its relevance to botulinum toxin comes from the practical aesthetics side of the market: facial anatomy, injection strategy, complication management, and cross-specialty discussion. It should be read as a clinical education and industry event, not as a source for product equivalence or superiority claims.
Website: Vegas Cosmetic Surgery & Aesthetic Dermatology 🔗
The Aesthetic Show
Section titled “The Aesthetic Show”The Aesthetic Show is a U.S. medical-aesthetics event associated with a multispecialty audience and an exhibition floor. Its official materials highlight injectables, aesthetic faculty, continuing education, exhibitors, and a broad mix of medical specialties practicing aesthetics.
The Aesthetic Show signals how botulinum toxin sits inside the broader aesthetics business ecosystem. It connects injector education, commercial exhibition, practice management, and product visibility rather than serving as a dedicated neurotoxin-science forum.
Website: The Aesthetic Show 🔗
AMWC Korea
Section titled “AMWC Korea”AMWC Korea extends the AMWC congress model into South Korea, one of the most visible aesthetic medicine markets and a major origin country for several botulinum toxin manufacturers. Its official site describes the Seoul event as a congress for aesthetic and anti-aging medical professionals, with scientific programming and an exhibition for products, technologies, and industry connections.
Its relevance is partly regional. Korea’s botulinum toxin industry includes domestic manufacturers, export brands, and international commercialization relationships, so a Korea-based aesthetics congress can help contextualize where clinical education, product visibility, and distribution interest meet.
Website: AMWC Korea 🔗
Event Context And Evidence Limits
Section titled “Event Context And Evidence Limits”Congress programs indicate which topics, techniques, and products are visible within a professional field. Scientific presentations can inform research context, while exhibitor and sponsor activity reflects commercial visibility rather than clinical evidence.
No meeting or exhibition should be used on its own to infer that two botulinum toxin products are interchangeable, unit-equivalent, equally approved, safer, stronger, longer-lasting, or clinically superior. Product-level interpretation still depends on labels, regulatory status, prescribing information, and high-quality clinical evidence.